The global Artificial Intelligence (AI) in Biotechnology Market was valued at USD 3.28 billion in 2024, expected to reach USD 13.30 billion by 2032, with a CAGR of 19.13%. The U.S. leads at USD 1.14 billion in 2024, projected to increase to USD 4.24 billion by 2032. Market growth is driven by AI integration in drug discovery, genomic sequencing, and clinical trial optimization.
The industry sees significant transformation through partnerships between biotech firms and AI innovators, supported by government funding. Demand for personalized medicine, biomarker discovery, and genomic diagnostics further contributes to market expansion. Pharmaceutical companies dominate with 38.3% market share, while CROs and CDMOs are the fastest-growing end-users.
In 2024, the software segment dominated the AI in biotechnology market with 46% revenue share, driven by its use in computational drug design and genomic analysis. Services are the fastest-growing segment. Drug discovery and development had the highest share in 2024, while clinical trials and optimization is the fastest-growing segment due to AI adoption for patient screening and trial design.
North America leads the AI in biotechnology market in 2024 due to robust R&D facilities and investments. The Asia Pacific market is projected to have the highest CAGR due to growing investments and digital healthcare. Insilico Medicine and Illumina have reported AI-enabled developments in drug discovery and genomic data processing, showcasing the efficacy of AI in biotechnology.
Exclusive sections of the report cover AI adoption rates, drug discovery projects, R&D efficiency gains, VC and government funding trends, patent filings, and collaboration indices. The market size was USD 5.14 billion in 2024, projected to reach USD 7.47 billion by 2032 with a CAGR of 4.8% from 2025 to 2032. Key segments include components, applications, end-users, and regional analysis. SNS Insider offers detailed analysis of the Artificial Intelligence (AI) in Biotechnology Market. With a focus on providing clients with accurate market data and consumer insights, the company utilizes various research techniques to ensure informed decision-making in a rapidly changing market landscape.
For more information or customization, contact SNS Insider at [email protected]. As a leading market research and consulting agency, SNS Insider aims to equip clients with the knowledge needed to thrive in evolving market conditions. Through surveys, video talks, and focus groups, the company delivers current and reliable market data to support confident decision-making.
Read more at GlobeNewswire: Artificial Intelligence (AI) in Biotechnology Market to Hit